Preterm premature rupture of membranes

Česká verze

Authors: V. Fulová ; Radovan Pilka
Authors place of work: Porodnicko-gynekologická klinika LF UP a FN Olomouc
Published in the journal: Ceska Gynekol 2023; 88(1): 27-32
Category: Přehledový článek
doi: https://doi.org/10.48095/cccg202327

Summary

Objectives: The aim of the presented work is to summarize the current knowledge about the pathophysiology of preterm birth in connection with premature amniotic fluid. Methods: To analyze current knowledge and our own experiences regarding of preterm prelabour rupture of membranes. Conclusion: The most important factor influencing neonatal morbidity and mortality is gestational age. Early neonatal sepsis occurs with high risk after premature amniotic fluid outflow, associated with inflammatory complications.

Keywords:

preterm prelabour rupture of membranes – intraamniotic infections

Zdroje

1. Kacerovský M. Předčasný odtok plodové vody před termínem porodu. 2018 [online]. Dostupné z: https: //www.labor-aktuell.cz/predcasny-odtok-plodove-vody-pred-terminem- porodu.

2. Meller CH, Carducci ME, Ceriani Cernadas JM et al. Preterm premature rupture of membranes. Arch Argent Pediatr 2018; 116 (4): e575–e581. doi: 10.5546/aap.2018.eng.e575.

3. Kim YM, Chaiworapongsa T, Gomez R et al. Failure of physiologic transformation of the spiral arteries in the placental bed in preterm premature rupture of membranes. Am J Obstet Gynecol 2002; 187 (5): 1137–1142. doi: 10.1067/mob.2002.127720.

4. Mercer MB. Preterm premature rupture of the membranes. Obstet Gynecol 2003; 101 (1): 179–193. doi: 10.1016/s0029-7844 (02) 02366-9.

5. Kacerovský M, Kokrdová Z, Koucký M et al. Předčasný odtok plodové vody před termínem porodu. Ceska Gynekol 2017; 82 (2): 166–167.

6. Tchirikov M, Schlabritz-Loutsevitch N, Maher J et al. Mid-trimester preterm premature rupture of membranes (PPROM): etiology, diagnosis, classification, international recommendations of treatment options and outcome. J Perinat Med 2018; 46 (5): 465–488. doi: 10.1515/ jpm- 2017-0027.

7. Kacerovsky M, Musilova I, Khatibi A et al. Intraamniotic inflammatory response to bacteria: analysis of multiple amniotic fluid proteins in women with preterm prelabor rupture of membranes. J Matern Fetal Neonatal Med 2012; 25 (10): 2014–2019. doi: 10.3109/147 67058.2012.671873.

8. Kacerovsky M, Pliskova L, Bolehovska R et al. The microbial load with genital mycoplasmas correlates with the degree of histologic chorioamnionitis in preterm PROM. Am J Obstet Gynecol 2011; 205 (3): 213.e1–213.e7. doi: 10.1016/j.ajog.2011.04.028.

9. Menon R, Peltier MR, Eckardt J et al. Diversity in cytokine response to bacteria associated with preterm birth by fetal membranes. Am J Obstet Gynecol 2009; 201 (3): 306.e1–306.e6. doi: 10.1016/j.ajog.2009.06.027.

10. Arntzen KJ, Kjøllesdal AM, Halgunset J et al. TNF, IL-1, IL-6, IL-8 and soluble TNF receptors in relation to chorioamnionitis and premature labor. J Perinat Med 1998; 26 (1): 17–26. doi: 10.1515/jpme.1998.26.1.17.

11. Smith G, Rafuse C, Anand N et al. Prevalence, management, and outcomes of preterm prelabour rupture of the membranes of women in Canada. J Obstet Gynaecol Can 2005; 27 (6): 547–553. doi: 10.1016/s1701-2163 (16) 30711-3.

12. Guzick DS, Winn K. The association of chorioamnionitis with preterm delivery. Obstet Gynecol 1985; 65 (1): 11–16.

13. Sbarra AJ, Selvaraj RJ, Cetrulo CL et al. Infection and phagocytosis as possible mechanisms of rupture in premature rupture of the membranes. Am J Obstet Gynecol 1985; 153 (1): 38–43. doi: 10.1016/0002-9378 (85) 90586-1.

14. Seo K, McGregor JA, French JI. Preterm birth is associated with increased risk of maternal and neonatal infection. Obstet Gynecol 1992; 79 (1): 75–80.

15. Romero R, Brody DT, Oyarzun E et al. Infection and labor. III. Interleukin-1: a signal for the onset of parturition. Am J Obstet Gynecol 1989; 160 (5 Pt 1): 1117–1123. doi: 10.1016/0002- 9378 (89) 90172-5.

16. Romero R, Mazor M, Sepulveda W et al. Tumor necrosis factor in preterm and term labor. Am J Obstet Gynecol 1992; 166 (5): 1576–1587. doi: 10.1016/0002-9378 (92) 91636-o.

17. Cobo T, Kacerovsky M, Palacio M et al. Intra-amniotic inflammatory response in subgroups of women with preterm prelabor rupture of the membranes. PLoS One 2012; 7 (8): e43677. doi: 10.1371/journal.pone.0043677.

18. Heinrich PC, Castell JV, Andus, T. Interleukin-6 and the acute phase response. Biochem J 1990; 265 (3): 621–636. doi: 10.1042/bj2650621.

19. Kameda T, Matsuzaki N, Sawai K et al. Production of interleukin-6 by normal human trophoblast. Placenta 1990; 11 (3): 205–213. doi: 10.1016/s0143-4004 (05) 80266-8.

20. Weeks JW, Reynolds L, Taylor D et al. Umbilical cord blood interleukin-6 levels and neonatal morbidity. Obstet Gynecol 1997; 90 (5): 815–818. doi: 10.1016/S0029-7844 (97) 00421-3.

21. Chaiworapongsa T, Espinoza J, Yoshimatsu J et al. Activation of coagulation system in preterm labor and preterm premature rupture of membranes. J Matern Fetal Neonatal Med 2002; 11 (6): 368–373. doi: 10.1080/jmf.11.6.368.373.

22. Rosen T, Kuczynski E, O’Neill LM et al. Plasma levels of thrombin-antithrombin complexes predict preterm premature rupture of the fetal membranes. J Matern Fetal Med 2001; 10 (5): 297–300. doi: 10.1080/714904361.

23. Lockwood CJ, Toti P, Arcuri F et al. Mechanisms of abruption-induced premature rupture of the fetal membranes: thrombin-enhanced interleukin-8 expression in term decidua. Am J Pathol 2005; 167 (5): 1443–1449. doi: 10.1016/ S0002-9440 (10) 61230-8.

24. Gómez R, Romero R, Nien JK et al. Idiopathic vaginal bleeding during pregnancy as the only clinical manifestation of intrauterine infection. J Matern Fetal Neonatal Med 2005; 18 (1): 31–37. doi: 10.1080/14767050500217863.

25. Gervasi MT, Chaiworapongsa T, Naccasha N et al. Maternal intravascular inflammation in preterm premature rupture of membranes. J Matern Fetal Neonatal Med 2002; 11 (3): 171–175. doi: 10.1080/jmf.11.3.171.175.

26. Østerud B, Bjorklid E. Sources of tissue factor. Semin Thromb Hemost 2006; 32 (1): 11–23. doi: 10.1055/s-2006-933336.

27. Mackenzie AP, Schatz F, Krikun G et al. Mechanisms of abruption-induced premature rupture of the fetal membranes: thrombin enhanced decidual matrix metalloproteinase-3 (stromelysin-1) expression. Am J Obstet Gynecol 2004; 191 (6): 1996–2001. doi: 10.1016/S0002- 9440 (10) 61230-8.

28. Rosen T, Schatz F, Kuczynski E et al. Thrombin-enhanced matrix metalloproteinase-1 expression: a mechanism linking placental abruption with premature rupture of the membranes. J Matern Fetal Neonatal Med 2002; 11 (1): 11–17. doi: 10.1080/jmf.11.1.11.17.

29. Elovitz MA, Saunders T, Ascher-Landsberg J et al. Effects of thrombin on myometrial contractions in vitro and in vivo. Am J Obstet Gynecol 2000; 183 (4): 799–804. doi: 10.1067/mob. 2000.108897.

30. Elovitz MA, Baron J, Phillippe M. The role of thrombin in preterm parturition. Am J Obstet Gynecol 2001; 185 (5): 1059–1063. doi: 10.1067/mob.2001.117638.

31. Lockwood CJ, Toti P, Arcuri F et al. Mechanisms of abruption-induced premature rupture of the fetal membranes: thrombin-enhanced interleukin-8 expression in term decidua. Am J Pathol 2005; 167 (5): 1443–1449. doi: 10.1016/S0002-9440 (10) 61230-8.

32. Cobo T, Jacobsson B, Kacerovsky M et al. Systemic and local inflammatory response in women with preterm prelabor rupture of membranes. PLoS One 2014; 9 (1): e85277. doi: 10.1371/journal.pone.0085277.

33. Abdel Gader AM, Al-Mishari AA, Awadalla SA et al. Total and free tissue factor pathway inhibitor in pregnancy hypertension. Int J Gynaecol Obstet 2006; 95 (3): 248–253. doi: 10.1016/ j.ijgo.2006.07.014.

34. Di Paolo S, Volpe P, Grandaliano G et al. Increased placental expression of tissue factor is associated with abnormal uterine and umbilical Doppler waveforms in severe preeclampsia with fetal growth restriction. J Nephrol 2003; 16 (5): 650–657.

35. Aharon A, Lanir N, Drugan A et al. Placental TFPI is decreased in gestational vascular complications and can be restored by maternal enoxaparin treatment. J Thromb Haemost 2005; 3 (10): 2355–2357. doi: 10.1111/j.1538-7836. 2005.01564.x.

36. Erez O, Espinoza J, Chaiworapongsa T et al. A link between a hemostatic disorder and preterm PROM: a role for tissue factor and tissue factor pathway inhibitor. J Matern Fetal Neonatal Med 2008; 21 (10): 732–744. doi: 10.1080/14767050802361807.

37. Romero R, Chaiworapongsa T, Kuivaniemi H. Bacterial vaginosis, the inflammatory response and the risk of preterm birth: a role for genetic epidemiology in the prevention of preterm birth. Am J Obstet Gynecol 2004; 190 (6): 1509–1519. doi: 10.1016/j.ajog.2004.01.002.

38. Procházka M, Procházková J, Ľubušký M et al. Trombofilní stavy v porodnictví – I. část. Prakt Gyn 2004; 4 (4): 12–17.

39. Alfirevic Z, Mousa HA, Martlew V et al. Postnatal screening for thrombophilia in women with severe pregnancy complications. Obstet Gynecol 2001; 97 (5 Pt 1): 753–759. doi: 10.1016/s0029-7844 (01) 01190-5.

40. Kupferminc MJ, Fait G, Many A et al. Severe preeclampsia and high frequency of thombophilic mutations. Obstet Gynecol 2000; 96 (1): 45–49. doi: 10.1016/s0029-7844 (00) 00 861-9.

41. Kvasnička J, Živný J. Trombotické stavy v těhotenství a v šestinedělí. Moderní gynekologie a porodnictví 1999; 8 (2): 144–151.

42. Friedrich PW, Sanson BJ, Simioni P et al. Frequency of pregnancy – related venous thromboembolism in antikoagulant factor deficient women: implications for profylaxis. Ann Intern Med 1996; 125 (12): 955–960. doi: 10.7326/ 0003-4819-125-12-199612150-00003.

43. Lockwood CJ. Heritable coagulopathies in pregnancy. Obstet Gynecol Surv 1999; 54 (12): 754–765. doi: 10.1097/00006254-199912000- 00004.

44. Yang J, Liang M. Risk factors for pregnancy morbidity in women with antiphospholipid syndrome. J Reprod Immunol 2021; 145: 103315. doi: 10.1016/j.jri.2021.103315.

45. Ghafoor S. Current and emerging strategies for prediction and diagnosis of prelabour rupture of the membranes: a narrative review. Malays J Med Sci 2021; 28 (3): 5–17. doi: 10.21315/mjms2021.28.3.2.

46. Kacerovsky M, Musilova I, Khatibi A et al. Intraamniotic inflammatory response to bacteria: analysis of multiple amniotic fluid proteins in women with preterm prelabor rupture of membranes. J Matern Fetal Neonatal Med 2012; 25 (10): 2014–2019. doi: 10.3109/14767058.2012. 671873.

47. Bohilțea RE, Cioca AM, Dima V et al. Expectant management of PPROM improves neonatal outcome – a retrospective study of 562 patients. J Clin Med 2022; 11 (1): 214. doi: 10.3390/jcm11010214.

48. Kacerovsky M, Tosner J, Andrys C et al. Amniotic fluid heat shock protein 70 concentration in preterm premature rupture of membranes. Ceska Gynekol 2009; 74 (2): 85–91.

49. Caughey AB, Robinson JN, Norwitz ER. Contemporary diagnosis and management of preterm premature rupture of membranes. Rev Obstet Gynecol 2008; 1 (1): 11–22.

50. Tsiarlas P, Kacerovsky M, Musilová P et al. The association between histological chorioamnionitis, funisitis and neonatal outcome in women with preterm prelabor rupture of membranes. J Matern Fetal Neonatal Med 2013; 26 (13): 1332–1336. doi: 10.3109/14767058.2013.784 741.

51. Buchanan S, Crowther C, Morris J. Preterm prelabour rupture of the membranes: a survey of current practice. Aust N Z J Obstet Gynaecol 2004; 44 (5): 400–403. doi: 10.1111/j.1479-828X.2004.00256.x.